National Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes
|
|
- Colin Greene
- 5 years ago
- Views:
Transcription
1 Natinal Hspital Inpatient Quality Reprting Measures Specificatins Manual Release Ntes Fr Manual Versin: 5.6 Cmpleted: Nvember 28, 2018 Guidelines fr Using Release Ntes The Release Ntes prvides mdificatins t the Specificatins Manual fr Natinal Hspital Inpatient Quality Measures, Versin 5.6. The infrmatin in this dcument is t be used as a reference and is nt intended t be used t prgram abstractin tls. Please refer t the Specificatins Manual fr Natinal Hspital Inpatient Quality Measures fr the cmplete and current technical specificatins and abstractin infrmatin. The ntes are rganized t fllw the rder f the Table f Cntents. The implementatin date is 07/01/2019, unless therwise specified. The headings are described belw: Impacts - used t identify the impacted measures and prtin(s) f the Manual Sectin, e.g., Alphabetical Data Dictinary, Measure Infrmatin Frm (MIF) and Flwchart (Algrithm). Descriptin f Changes - used t identify the sectin within the dcument where the change ccurs, e.g., Definitin, Data Cllectin Questin, Allwable Values, and Denminatr Statement - Data Elements. Ratinale - prvided fr the change being made. Data elements that crss multiple measures and cntain the same changes will be cnslidated. NOTE: In additin t being called ut specifically in the Release Ntes dcument, additins are yellw highlighted in the crrespnding dcuments. The changes in the Hspital Initial Patient Ppulatin and Clinical Data XML File Layuts have yellw highlighted cells with actual changes nted in bld fnt.
2 Table f Cntents Nte: click n any sectin title in the Release Ntes t return t Table f Cntents page. Table f Cntents (n updates)... 2 Acknwledgement (n updates)... 2 Intrductin (n updates)... 2 Using the Specificatins Manual fr Natinal Hspital Inpatient Quality Measures (n updates)... 2 SECTION 1 Data Dictinary... 2 Intrductin t Data Dictinary (n updates)... 2 Alphabetical Data Dictinary... 2 SECTION 2 Measurement Infrmatin Subsectin 2.1 Severe Sepsis and Septic Shck (SEP) (n updates) Subsectin 2.2 Venus Thrmbemblism (VTE) Subsectin 2.4 Glbal Initial Patient Ppulatin (ED, IMM, TOB, SUB) (n updates) Subsectin 2.5 Emergency Department (ED) Subsectin Preventin Immunizatin (IMM) Substance Use (SUB) (n updates) Tbacc Treatment (TOB) (n updates) SECTION 3 Missing and Invalid Data (n updates) SECTION 4 Ppulatin and Sampling Specificatins (n updates) SECTION 9 Data Transmissin Transmissin Overview (n updates) Transmissin Alphabetical Data Dictinary (n updates) Hspital Clinical Data XML File Layut Hspital Initial Patient Ppulatin Data XML File Layut (n updates) SECTION 10 CMS Outcme/Inpatient Web-Based Measures Subsectin 10.1 CMS Outcme Measures (n updates) Subsectin 10.2 Inpatient Web-Based Measures (n updates) APPENDICES Appendix A ICD-10 Cde Tables (Wrd and Excel) (n updates) Appendix C Medicatin Tables (Wrd and Excel) Appendix D Glssary f Terms (n updates) Appendix E Overview f Measure Infrmatin Frm and Flwchart Frmats (n updates) Appendix F Measure Name Crsswalk (n updates) Appendix G Resurces (n updates) Appendix H Miscellaneus Tables Appendix P Preview Sectin (n updates) Specificatins Manual fr Hspital Inpatient Quality Measures Page 1
3 The cntent belw is rganized t fllw the Table f Cntents in the specificatins manual. Table f Cntents (n updates) Acknwledgement (n updates) Intrductin (n updates) Using the Specificatins Manual fr Natinal Hspital Inpatient Quality Measures (n updates) SECTION 1 Data Dictinary Intrductin t Data Dictinary (n updates) Alphabetical Data Dictinary Administrative Cntraindicatin t Care, Septic Shck Ratinale: The Administrative Cntraindicatin t Care, Septic Shck data element is being updated with new guidance. Change third bullet pint t: A mre general dcumentatin f refusal f care (e.g. central line, PICC, IO access) r dcumentatin f patient nn-cmpliance with care (e.g., pulling ut IV) that wuld result in the fllwing nt being administered within the specified time frame is acceptable. Bld Draws IV r IO fluid administratin Vaspressrs Administrative Cntraindicatin t Care, Severe Sepsis Ratinale: The Administrative Cntraindicatin t Care, Severe Sepsis data element is being updated with new guidance. Change third bullet pint t: A mre general dcumentatin f refusal f care (e.g. central line, PICC, IO access) r dcumentatin f patient nn-cmpliance with care (e.g., pulling ut IV) that wuld result in the fllwing nt being administered within the specified time frame is acceptable. Bld Draws IV r IO fluid administratin Vaspressrs Specificatins Manual fr Hspital Inpatient Quality Measures Page 2
4 Brad Spectrum r Other Antibitic Administratin Selectin Ratinale: The Brad Spectrum r Other Antibitic Administratin Selectin data element is being updated with new guidance. Change under fifth bullet pint, Examples t: Example: Change first sub-bullet pint under sixth bullet pint t: There is physician/apn/pa dcumentatin within 24 hurs prir t the antibitic start time identifying the presence f C. difficile. Dcumentatin that C. difficile is suspected r likely is acceptable. Directive fr Cmfrt Care r Palliative Care, Septic Shck Ratinale: The Directive fr Cmfrt Care, Septic Shck data element is being updated with new guidance t further specify that nly inclusin terms dcumented in specific cntext are acceptable. Change secnd bullet pint t: Only the earliest physician/apn/pa dcumentatin f an inclusin term dcumented in the fllwing cntexts suffices: Cmfrt measures nly recmmendatin Order fr cnsultatin r evaluatin by a hspice care service Patient r patient representative request fr cmfrt measures nly Plan fr cmfrt measures nly Referral t hspice care service Directive fr Cmfrt Care r Palliative Care, Severe Sepsis Ratinale: The Directive fr Cmfrt Care, Septic Shck data element is being updated with new guidance t further specify that nly inclusin terms dcumented in specific cntext are acceptable. Change secnd bullet pint t: Only the earliest physician/apn/pa dcumentatin f an inclusin term dcumented in the fllwing cntexts suffices: Cmfrt measures nly recmmendatin Order fr cnsultatin r evaluatin by a hspice care service Patient r patient representative request fr cmfrt measures nly Plan fr cmfrt measures nly Referral t hspice care service Specificatins Manual fr Hspital Inpatient Quality Measures Page 3
5 Discharge Dispsitin Ratinale: The data element is being updated t prvide abstractin guidance regarding dcumentatin related t patient discharge t rehabilitatin facilities fr chemical and alchl dependency. Inclusin Guidelines fr Abstractin Under Other Health Care Facility (Value 5): Change fifth bullet pint t: Rehabilitatin Facility including, but nt limited t: Inpatient Rehabilitatin Facility/Hspital, Rehabilitatin Unit f a Hspital, Chemical Dependency/Alchl Rehabilitatin Facility Initial Hyptensin Ratinale: The Initial Hyptensin data element is being updated with clarifying guidance. Change furth bullet pint t: Hyptensive BPs btained within the perating rm (OR), interventinal radilgy, during active delivery, r prcedural/cnscius sedatin shuld nt be used. Change seventh bullet pint t: Dcumentatin f a term that represents r is defined by an SBP <90 mmhg r MAP <65 mmhg is acceptable in place f an abnrmal value when dcumented as nrmal fr the patient, due t a chrnic cnditin, due t a medicatin, r due t an acute cnditin that has a nn-infectius surce/prcess. Example: Hyptensin (Systlic bld pressure <90 mmhg). Persistent Hyptensin Ratinale: The Persistent Hyptensin data element is being updated with clarifying guidance. Change third bullet pint t: Hyptensive BPs btained within the perating rm (OR), interventinal radilgy, during active delivery, r prcedural/cnscius sedatin shuld nt be used. Add new sixth bullet pint: If ne r mre bld pressures were dcumented within the time frame and persistent hyptensin is unable t be determined but a vaspressr was administered, select Value 1. Change eighth bullet pint t: Dcumentatin f a term that represents r is defined by an SBP <90 mmhg r MAP <65 mmhg is acceptable in place f an abnrmal value when dcumented as nrmal fr Specificatins Manual fr Hspital Inpatient Quality Measures Page 4
6 the patient, due t a chrnic cnditin, due t a medicatin, r due t an acute cnditin that has a nn-infectius surce/prcess. Example: Hyptensin (Systlic bld pressure <90 mmhg). Remve: Acceptable crystallid fluids are identified in the Crystallid Fluid Administratin data element. If the end time f the target rdered vlume f crystallid fluids cannt be determined, select Value 3. If crystallid fluids were administered but at a vlume less than the target rdered vlume, chse Value 4. Reasn fr N Administratin f VTE Prphylaxis Ratinale: The data element is being updated t prvide additinal guidance fr the abstractr. Change under secnd bullet pint, third sub-bullet pint t: Fr patients receiving anticagulant therapy, including cntinuus IV heparin infusin, between arrival and the day befre the VTE diagnstic test rder date, select Yes. Disregard IV heparin administered t flush/maintain patency f a line r dialysis equipment and IV heparin administered during an interventinal prcedure, e.g., cardiac cath. Remve furth bullet pint: If the VTE Diagnstic Test was perfrmed the day f r the day after arrival, select Yes. Referral fr Addictins Treatment Ratinale: The data element is being updated t prvide abstractin guidance regarding dcumentatin related t patient referrals and appintments fr addictins treatment. Change t: If a patient is referred t an addictins treatment prvider that des nt schedule appintments and the patient was given a specific date and time t present fr addictins treatment, select Value 1. If the patient des nt have a residence in the USA, Value 4 must be selected. A referral t Alchlics Annymus (AA) r similar mutual supprt grups des nt meet the intent f the measure. Select Value 5. Select Value 5 if: it cannt be determined that a referral fr addictins treatment was made r; it is unclear that the absence f the referral was due t a patient refusal r because the referral was nt ffered. Specificatins Manual fr Hspital Inpatient Quality Measures Page 5
7 Referral fr Outpatient Tbacc Cessatin Cunseling Ratinale: The data element is being updated t prvide abstractin guidance regarding dcumentatin related t patient referrals and appintments fr addictins treatment. Change t: If a referral is made t a Quitline, defined as a telephne cunseling in which at least sme f the cntact is initiated by the Quitline cunselr t deliver tbacc use interventins, select Value 1. If the patient directly calls the Quitline during the hspitalizatin, dcumentatin must reflect that staff was present during the call t verify that an appintment was set. If a patient is referred t an utpatient tbacc cessatin cunseling prvider that des nt schedule appintments and the patient was given a specific date and time t present fr cunseling, select Value 1. If the patient is prvided with cntact infrmatin fr e-health r internet smking cessatin prgrams which tailr prgram cntent t the tbacc user s needs (by cllecting infrmatin frm the tbacc user and using algrithms t tailr feedback r recmmendatins, permitting the user t select frm varius features including extensive infrmatin n quitting, tbacc dependence, and related tpics) select Value 2. Nte that if Value 2 is selected, the case will nt pass the measure. Value 2 can be used as part f an internal perfrmance imprvement activity in rder t determine if any type f referral was made rather than n referral. If a referral fr utpatient tbacc cessatin cunseling was ffered during the hspitalizatin and the patient refused, select Value 3. It des nt need t be ffered again at discharge. If the patient des nt have a residence in the USA, Value 4 must be selected. If the patient is prvided with self-help materials that are nt tailred t the patient s needs and d nt prvide a structured prgram, select Value 5. Select Value 5 if: it cannt be determined that a referral fr utpatient cessatin cunseling was made r; it is unclear that the absence f the referral was due t a patient refusal r because the referral was nt ffered. If the patient refused practical cunseling (Tbacc Use Treatment Practical Cunseling) during the hspitalizatin, a referral fr utpatient tbacc cessatin cunseling must still be ffered at the time f discharge. Select Value 5 if a referral fr utpatient cunseling was nt ffered at the time f discharge. Severe Sepsis Present Ratinale: The Severe Sepsis Present data element is being updated with new guidance. Change under secnd bullet pint, eighth bullet pint under C t: INR >1.5 r aptt >60 sec Specificatins Manual fr Hspital Inpatient Quality Measures Page 6
8 Release Ntes Versin 5.6 If the suggested data surce shws the patient was given an anticagulant medicatin in Appendix C Table 5.3, an elevated INR r aptt level shuld nt be used as rgan dysfunctin. Physician/APN/PA dcumentatin is nt required. If nly the fllwing is given, the elevated INR r aptt level shuld be used: Heparin flushes Change furth bullet pint t: Dcumentatin f a term that represents r is defined by a SIRS criteria r sign f rgan dysfunctin is acceptable in place f an abnrmal value when dcumented as nrmal fr the patient, due t a chrnic cnditin, due t a medicatin, r due t an acute cnditin that has a nn-infectius surce/prcess. Examples include but are nt limited t: Tachypnea (Respiratin >20 per minutes) Tachycardia, RVR (Heart rate >90) Leukpenia (White bld cell cunt <4,000) Leukcytsis (White bld cell cunt >12,000) Thrmbcytpenia (Platelet cunt <100,000) Hyptensin (Systlic bld pressure <90 mmhg) Change seventh bullet pint t: SIRS criteria r a sign f rgan dysfunctin btained within the perating rm (OR), interventinal radilgy, during active delivery, r prcedural/cnscius sedatin shuld nt be used. Septic Shck Present Ratinale: The Septic Shck Present data element is being updated with clarifying guidance. Change a under third bullet pint t: a. Severe Sepsis Present AND Persistent Hyptensin evidenced by: In the hur after the cnclusin f the target rdered vlume f Crystallid Fluid Administratin, tw cnsecutive dcumented hyptensive bld pressure readings. Change furth and fifth bullet pint t: Fr evaluatin f bld pressure parameters t establish whether r nt hyptensin persists after crystallid fluid administratin, begin abstracting at the time that crystallid fluid administratin cncludes (refer t the Persistent Hyptensin data element); abstract fr the time perid that fllws fr the next hur nly. Hyptensive BPs btained within the perating rm (OR), interventinal radilgy, during active delivery, r prcedural/cnscius sedatin shuld nt be used. Change ninth bullet pint t: Dcumentatin f a term that represents r is defined by a SBP <90 mmhg r MAP <65 mmhg is acceptable in place f an abnrmal value when dcumented as nrmal fr the patient, due t a chrnic cnditin, due t a medicatin, r due t an acute cnditin that has a nn-infectius surce/prcess. Specificatins Manual fr Hspital Inpatient Quality Measures Page 7
9 VTE Cnfirmed Ratinale: The data element is being updated t prvide additinal guidance fr the abstractr. Inclusin Guidelines fr Abstractin Add new bullet pint: Infrarenal IVC Exclusin Guidelines fr Abstractin Add new bullet pints: Amnitic fluid emblism / embli Cement emblism / embli VTE Diagnstic Test Ratinale: The data element is being updated t prvide additinal guidance fr the abstractr. Inclusin Guidelines fr Abstractin Change secnd bullet pint t: Venus Ultrasund f lwer extremities Add new bullet pint: CT pulmnary angigram (CTPA) / CTPA Scan / CT pulmnary emblism (CTPE) VTE Present at Admissin Ratinale: The data element is being updated t prvide additinal guidance fr the abstractr. Change t: The time frame fr this data element includes any dcumentatin dated frm hspital arrival t the day after admissin. It is nt necessary t review dcumentatin utside f this timeframe t answer this data element. Dcumentatin f suspicin r a diagnsis f a pulmnary emblism (PE) r venus thrmbemblism (VTE) in a cnfirmed lcatin is acceptable. Only accept terms identified in the list f inclusins. NOTE: It is nt necessary fr a VTE Diagnstic Test t be linked with the physician/apn/pa dcumented diagnsis f PE r VTE. Acceptable Examples: A patient arrived n 10/1/20xx with shrtness f breath. On 10/2/20XX, there is physician dcumentatin that a PE is suspected, select Yes. Results f a venus Dppler perfrmed the day after admissin are psitive fr VTE in the cmmn femral vein, select Yes. Specificatins Manual fr Hspital Inpatient Quality Measures Page 8
10 Release Ntes Versin 5.6 Results f a Dppler are psitive fr an acute nncclusive LLE thrmbus n the day after admissin, select Yes. Day f admissin physician includes PE n the prblem list, select Yes. Patient admitted with a diagnsis f left ppliteal deep vein thrmbus, select Yes. Patient arrived n 01/05/20XX with dcumentatin frm an utside transferring hspital indicating vascular ultrasund was perfrmed n 01/02/20XX and psitive fr VTE, select Yes. Physician dcuments in H&P n day f admissin, DVT right lwer extremity, select Yes. Unacceptable Examples: H&P n day f admissin ntes that the patient has an cclusin f the subclavian vein. Subclavian vein is nt a defined lcatin, select N. A patient arrives t the hspital emergency department with C/O severe headache. Differential diagnsis n the day f arrival includes cerebral venus thrmbsis (CVT) versus SAH, select N. Physician admitting nte dcuments DVT prphylaxis under the treatment plan, select N. Patient admitted with a diagnsis f left upper extremity deep vein thrmbus, select N. Patient has a CT chest with IV cntrast n the day f arrival t R/O PE and test results are negative and received by 2359 the day after admissin, select N. An rder fr a VTE diagnstic test is acceptable ONLY if it is explicitly dcumented that VTE/PE is the reasn fr the test. Only accept terms identified in the list f inclusins. If an acceptable test is rdered fr a PE r VTE indicatin and results are dcumented as negative by 2359 the day after admissin, then suspicin f PE r VTE has been ruled ut. Select N. Acceptable Examples: A patient presents t the hspital emergency department with a chief cmplaint f pain and swelling in the right calf. A vascular ultrasund f the lwer extremities is rdered t R/O DVT, select Yes. UNLESS results are negative and received by 2359 the day after admissin. Bilateral venus Dppler f the lwer extremities is rdered n the day after admissin fr redness and swelling left calf, select Yes. A patient arrives n 06/01/20XX. Admitting diagnsis is fever. On 06/02/20XX patient admitted and physician dcuments if cugh cntinues may require evaluatin fr PE. On 06/03/20XX, CTA chest is rdered and psitive fr PE. Select Yes. Unacceptable Examples: Physician rders a bilateral lwer extremity arterial duplex n the day after admissin. Arterial duplex is nt an acceptable test. Select "N" fr VTE Present n Admissin. Patient presents t the emergency rm with cmplaints f pain all ver after sustaining a fall. ED MD rders multiple tests including a CT f the chest with IV cntrast. ED MD dcuments fall as the reasn fr the test. N mentin f PE/VTE, select N. Specificatins Manual fr Hspital Inpatient Quality Measures Page 9
11 Release Ntes Versin 5.6 A patient is admitted after a mtr vehicle accident. On arrival, a CT f the abd/pelvis with IV cntrast was dne t R/O internal injuries. N mentin f PE/VTE, select N. Bilateral venus Dppler f the lwer extremities is rdered n the day f arrival fr redness and swelling left calf. Results returned the same day dcument n acute VTE in left cmmn femral vein r ppliteal vein, select N. Patients wh are under treatment and receiving anticagulatin therapy fr PE/VTE at the time f hspital arrival, select Yes. Examples: Patient admitted 04/30/20XX. Physician dcuments n 04/30/20XX that Cumadin was started n 04/20/20XX fr a recently diagnsed PE, select Yes. Patient presents with a dcumented diagnsis f PE n the day f arrival. Cumadin placed n hld t evaluate fr GI bleed, select Yes. Patients n anticagulatin therapy fr anther cnditin (e.g., atrial fibrillatin, mitral valve replacement) at the time f hspital arrival, select Yes. Examples: Patient with a histry f strke and taking dabigatran as a hme medicatin prir t arrival, select YES. H&P dcuments chrnic VTE. Taking Cumadin, select Yes. EXCEPTION: Patient n apixaban prir t arrival fr a histry f atrial fibrillatin. Apixaban discntinued n arrival fr surgery the day after admissin, select N. Fr patients with nly a past histry f VTE dcumented, select N. Example: Prblem list includes PE 199X, select N. If the patient was admitted and had surgery n day f r day after hspital admissin r ICU admissin and there was n dcumentatin f diagnsed/suspected VTE prir t surgery, the VTE is nt cnsidered present n admissin. Select N. Disregard diagnstic prcedures perfrmed, e.g., cardiac catheterizatin, endscpy, ERCP. Inclusin Guidelines fr Abstractin VTE Cnfirmed Add new bullet pint: Infrarenal IVC Inclusin Guidelines fr Abstractin VTE Diagnstic Test Change secnd bullet pint t: Venus Ultrasund f lwer extremities Add new bullet pint: CT pulmnary angigram (CTPA) / CTPA Scan / CT pulmnary emblism (CTPE) Specificatins Manual fr Hspital Inpatient Quality Measures Page 10
12 SECTION 2 Measurement Infrmatin Subsectin 2.1 Severe Sepsis and Septic Shck (SEP) (n updates) Subsectin 2.2 Venus Thrmbemblism (VTE) VTE Data Element List Ratinale: The VTE Data Element List is being updated t remve data elements nt cllected by The Jint Cmmissin, the current measure steward. Remve rws in their entirety: First Name Last Name Patient Identifier Physician 1 Physician 2 Pstal Cde Sample Size Requirements Quarterly Sampling Ratinale: This dcument is being updated t remve the references t CMS. Remve frm first paragraph and under Quarterly Sampling sectin: the CMS Clinical Warehuse r Subsectin 2.4 Glbal Initial Patient Ppulatin (ED, IMM, TOB, SUB) (n updates) Subsectin 2.5 Emergency Department (ED) ED-1: Algrithm Ratinale: This dcument is being updated t align with fiscal year (FY) 2019 Inpatient Prspective Payment System (IPPS) final rule and the remval f ED-1 frm the Hspital IQR Prgram. Remve the fllwing ntes and decisin bx: Fr Overall Measure (ED-1a) Fr The Jint Cmmissin Only ff f the Case Will Be Rejected decisin pint Stp here fr CMS. CONTINUE fr The Jint Cmmissin decisin pint Nte: X is fr The Jint Cmmissin Only Specificatins Manual fr Hspital Inpatient Quality Measures Page 11
13 Subsectin Preventin Immunizatin (IMM) IMM Data Element List Ratinale: The IMM Data Element List is being updated t remve data elements nt cllected by The Jint Cmmissin, the current measure steward. Remve rws in their entirety: First Name Last Name Patient Identifier Physician 1 Physician 2 Pstal Cde Substance Use (SUB) (n updates) Tbacc Treatment (TOB) (n updates) SECTION 3 Missing and Invalid Data (n updates) SECTION 4 Ppulatin and Sampling Specificatins (n updates) SECTION 9 Data Transmissin Transmissin Overview (n updates) Transmissin Alphabetical Data Dictinary (n updates) Hspital Clinical Data XML File Layut Data Elements Inf Ratinale: Updates are being made t align with the specificatins manual alphabetical data dictinary. Change Retired r Deleted Data Elements Effective 07/01/2019 Discharges sectin t: N elements retired r deleted. Hspital Initial Patient Ppulatin Data XML File Layut (n updates) SECTION 10 CMS Outcme/Inpatient Web-Based Measures Subsectin 10.1 CMS Outcme Measures (n updates) Subsectin 10.2 Inpatient Web-Based Measures (n updates) Specificatins Manual fr Hspital Inpatient Quality Measures Page 12
14 APPENDICES Appendix A ICD-10 Cde Tables (Wrd and Excel) (n updates) Appendix C Medicatin Tables (Wrd and Excel) Table 5.2: Vaspressrs fr Septic Shck Ratinale: Table 5.2 is being updated t include Giapreza (angitensin II), an injectin recently apprved by the U.S. Fd and Drug Administratin t increase bld pressure in adults with septic r ther distributive shck. Add rw under Generic Name and crrespnding Brand Name clumns: Angitensin II t left clumn Giapreza t right clumn Appendix D Glssary f Terms (n updates) Appendix E Overview f Measure Infrmatin Frm and Flwchart Frmats (n updates) Appendix F Measure Name Crsswalk (n updates) Appendix G Resurces (n updates) Appendix H Miscellaneus Tables Table 2.6 Ratinale: Table 2.6 is being remved as it is n lnger utilized fr any f the measure sets. Remve in its entirety: Table 2.6: Qualifiers and Mdifiers Table Appendix P Preview Sectin (n updates) Specificatins Manual fr Hspital Inpatient Quality Measures Page 13
National Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes
Natinal Hspital Inpatient Quality Reprting Measures Specificatins Manual Release Ntes Fr Manual Versin: 5.3 Cmpleted: June 15, 2017 Guidelines fr Using Release Ntes The Release Ntes prvides mdificatins
More informationNational Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes
Natinal Hspital Inpatient Quality Reprting Measures Specificatins Manual Release Ntes Fr Manual Versin: 5.4 Cmpleted: Nvember 27, 2017 Guidelines fr Using Release Ntes The Release Ntes prvides mdificatins
More informationNational Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes
Natinal Hspital Inpatient Quality Reprting Measures Specificatins Manual Release Ntes Fr Manual Versin: 5.5 Cmpleted: June 14, 2018 Guidelines fr Using Release Ntes The Release Ntes prvides mdificatins
More informationQUALITY AND SAFETY MEASURES UPDATE January 2016
CLINICAL EFFECTIVENESS/SAFETY M CORE MEASURES 2015 See attached Results QUALITY AND SAFETY MEASURES UPDATE January 2016 Jint Cmmissin and CMS Cre Measure Dashbard updated with mst recent data available:
More information2017 CMS Web Interface
CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY
More informationCardiac Rehabilitation Services
Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin
More informationHeart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or
Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): Angitensin
More information2017 CMS Web Interface
CMS Web Interface PREV-6 (NQF 0034): Clrectal Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY
More informationHeart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or
Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): EMeasure
More informationCSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009
CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral
More information2017 CMS Web Interface
CMS Web Interface CARE-2 (NQF 0101): Falls: Screening fr Future Fall Risk Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION...
More information2018 CMS Web Interface
CMS Web Interface HTN-2 (NQF 0018): Cntrlling High Bld Pressure Measure Steward: NCQA CMS Web Interface V2.0 Page 1 f 18 11/13/2017 Cntents INTRODUCTION... 3 CMS WEB INTERFACE SAMPLING INFORMATION... 4
More informationCoronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070)
Crnary Artery Disease (CAD): Beta Blcker Therapy fr CAD Patients with Prir Mycardial Infarctin (MI) (NQF 0070) EMeasure Name Crnary Artery Disease EMeasure Id Pending (CAD): Beta Blcker Therapy fr CAD
More informationACRIN 6666 Screening Breast US Follow-up Assessment Form
Screening Breast US Fllw-up Assessment Frm N. Instructins: The frm is cmpleted at 12, 24 and 36 mnths pst initial n study mammgraphy and ultrasund by the Radilgist r RA. Reprt all interim infrmatin related
More informationWound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018
Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered
More informationWaterloo Wellington Rehabilitative Care System Integrated Care Pathway for STROKE Stream of Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION
Waterl Wellingtn Rehabilitative Care System Integrated Care Pathway fr STROKE Stream f Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION Care Setting Activity Patients wh present t a cmmunity
More information2018 CMS Web Interface
CMS Web Interface MH-1 (NQF 0710): Depressin Remissin at Twelve Mnths Measure Steward: MNCM CMS Web Interface V2.1 Page 1 f 27 06/25/ Cntents INTRODUCTION... 4 CMS WEB INTERFACE SAMPLING INFORMATION...
More informationNational Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)
Questin GENERAL Why did MHS implement a Medical Specialty Slutins Prgram? Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Managed Health Services (MHS) Answer Effective Nvember
More informationNational Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers
Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQ s) Fr PA Health & Wellness Prviders Questin GENERAL Why is PA Health & Wellness implementing a Medical Specialty Slutins Prgram? Answer
More information2018 CMS Web Interface
CMS Web Interface MH-1 (NQF 0710): Depressin Remissin at Twelve Mnths Measure Steward: MNCM CMS Web Interface V2.0 Page 1 f 27 11/13/2017 Cntents INTRODUCTION... 4 CMS WEB INTERFACE SAMPLING INFORMATION...
More informationHealth Screening Record: Entry Level Due: August 1st MWF 150 Entry Year
Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic
More informationNational Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers
Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Luisiana Healthcare Cnnectins Prviders Questin GENERAL Why did Luisiana Healthcare Cnnectins implement a Medical Prgram? Answer
More informationBariatric Surgery FAQs for Employees in the GRMC Group Health Plan
Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select
More informationBenefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria
Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health
More information2018 CMS Web Interface
CMS Web Interface Diabetes Mellitus (DM) Cmpsite (All r Nthing Scring) DM-2 (NQF 0059): Diabetes: Hemglbin A1c (HbA1c) Pr Cntrl (>9%) DM-7 (NQF Measure Steward: NCQA CMS Web Interface V2.1 Page 1 f 26
More informationChildhood Immunization Status (NQF 0038)
Childhd Immunizatin Status (NQF 0038) EMeasure Name Childhd Immunizatin EMeasure Id Pending Status Versin Number 1 Set Id Pending Available Date N infrmatin Measurement Perid January 1, 20xx thrugh December
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationMeasure Information Form
Release Ntes: Measure Infrmatin Frm Versin 2.0 **NQF-ENDORSED VOLUNTRY CONSENSUS STNDRDS FOR HOSPITL CRE** Measure Set: Heart Failure (HF) Set Measure ID#: Measure Infrmatin Frm Perfrmance Measure Name:
More information2018 CMS Web Interface
CMS Web Interface PREV-12 (NQF 0418): Preventive Care and Screening: Screening fr Depressin and Measure Steward: CMS CMS Web Interface V2.1 Page 1 f 23 06/25/ Cntents INTRODUCTION... 3 CMS WEB INTERFACE
More informationLTCH QUALITY REPORTING PROGRAM
4 LTCH QUALITY REPORTING PROGRAM GENERAL INFORMATION...3 LTCH FACILITY-LEVEL QUALITY MEASURE REPORT...5 LTCH PATIENT-LEVEL QUALITY MEASURE REPORT...18 LTCH REVIEW AND CORRECT REPORT...23 09/2018 v1.04
More information2018 Medical Association Poster Symposium Guidelines
2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the
More information2017 CMS Web Interface
CMS Web Interface Diabetes Mellitus (DM) Cmpsite (All r Nthing Scring) DM-2 (NQF 0059): Diabetes: Hemglbin A1c (HbA1c) Pr Cntrl (>9%) DM-7 (NQF 0055): Diabetes: Eye Exam Measure Steward: NCQA Web Interface
More information2017 CMS Web Interface
CMS Web Interface PREV-12 (NQF 0418): Preventive Care and Screening: Screening fr Depressin and Fllw-Up Measure Steward: CMS Web Interface V1.0 Page 1 f 22 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE
More informationReferral Criteria: Inflammation of the Spine Feb
Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses
More informationCLINICAL MEDICAL POLICY
Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019
More informationSolid Organ Transplant Benefits to Change for Texas Medicaid
Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a
More informationTips & Tricks COMPASS Improvements March 5, 2014
DCMC, SMCH, SMCW Tips & Tricks COMPASS Imprvements March 5, 2014 Infrmatin fr All Practitiners Regardless f Specialty... 1 Epiphany Diagnstic Tests and Results in COMPASS... 1 New Diagnstics Tab in Flwsheets
More informationTOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH
Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,
More informationOTHER AND UNSPECIFIED DISORDERS
OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...
More informationService Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin
Service Change Prcess Gateway 1 High-level Prpsitin Innvatin prject name: Patient Self-Mnitring/Management f Warfarin NHS Bury Please describe the service change being prpsed. Please describe what service(s)
More informationRelated Policies None
Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER
More information2018 CMS Web Interface
CMS Web Interface IVD-2 (NQF 0068): Ischemic Vascular Disease (IVD): Use f Aspirin r Anther Measure Steward: NCQA CMS Web Interface V2.0 Page 1 f 20 11/13/2017 Cntents INTRODUCTION... 3 CMS WEB INTERFACE
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationNIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO
NIA Magellan 1 Spine Care Prgram Interventinal Pain Management Frequently Asked Questins (FAQs) Fr Medicare Advantage HMO and PPO Questin GENERAL Why is Flrida Blue implementing a Spine Management prgram
More information1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT
WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU
More information2018 CMS Web Interface
PREV-13: Statin Therapy fr the Preventin and Treatment f Cardivascular Disease CMS Web Interface PREV-13: Statin Therapy fr the Preventin and Treatment f Cardivascular Disease Measure Steward: CMS CMS
More information2018 CMS Web Interface
CMS Web Interface PREV-13: Statin Therapy fr the Preventin and Treatment f Cardivascular Disease Measure Steward: CMS CMS Web Interface V2.1 Page 1 f 27 06/25/ Cntents INTRODUCTION... 4 CMS WEB INTERFACE
More informationEmergency Department Performance Measures
Emergency Department Perfrmance Measures ACEP Clinical Emergency Data Registry () ACEP Campaign Centers fr Medicare and Medicaid Services (CMS) Medicare Beneficiary Quality Imprvement Prject (MBQIP) ED
More informationCOPD Outreach Program
COPD Outreach Prgram Wendy Laframbise, Advanced Practice Nurse Certified Respiratry Educatr COPD Outreach Prgram March, 2015 Disclaimer: The Canadian Fundatin fr Healthcare Imprvement (CFHI), in partnership
More information2017 CMS Web Interface
CMS Web Interface PREV-13: Statin Therapy fr the Preventin and Treatment f Cardivascular Disease Measure Steward: CMS Web Interface V1.1 Page 1 f 27 12/15/2016 Cntents INTRODUCTION... 4 WEB INTERFACE SAMPLING
More informationMEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache
MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache Measure Descriptin All patients diagnsed with migraine headache r cervicgenic headache wh had a headache management
More informationHEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.
HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,
More informationo Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient
Image Surce: https://s-media-cache-ak0.pinimg.cm/736x/7c/29/91/7c2991805f004e1ca05e42a79883f4a7.jpg 6/30/2017 Curse Objectives A Practical Guide t Cding fr Audilgists in 2017 Megan Keirans, AuD University
More informationClinical Study Synopsis
Clinical Study Synpsis This Clinical Study Synpsis is prvided fr patients and healthcare prfessinals t increase the transparency f Bayer's clinical research. This dcument is nt intended t replace the advice
More informationUNM SRMC SLEEP MEDICINE CLINICAL PRIVILEGES.
Initial privileges (initial appintment) Renewal f privileges (reappintment) Expansin f privileges (mdificatin) INSTRUCTIONS All new applicants must meet the fllwing requirements as apprved by the UNM SRMC
More informationAppendix C SCHEDULE OF BENEFITS FOR THE LOW COST MEDICAL PLAN OF BENEFITS
Appendix C SCHEDULE OF BENEFITS FOR THE LOW COST MEDICAL PLAN OF BENEFITS The schedule n the fllwing pages highlights key features f the Lw Cst Medical Plan f Benefits fr Cvered Individuals. These benefits
More informationRecord of Revisions to Patient Tracking Spreadsheet Template
Recrd f Revisins t Patient Tracking Spreadsheet Template Belw is a recrd f revisins made by the AIMS Center t the Patient Tracking Spreadsheet Template. The purpse f this dcument is t infrm spreadsheet
More informationDear Student, IMMUNIZATION RECORD INSTRUCTIONS
Dear Student, Welcme t the University f Chicag! The State f Illinis and University regulatins require students t prvide prf f required immunizatins prir t registratin fr classes. In rder t cmplete this
More informationPatrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip
Patrick J McGahan, MD Orthpaedic Surgen Specializing in Sprts Medicine/Shulder Recnstructin 2801 K St, Ste 330, Sacrament, CA, 95816 (p) 916-733-5049 (f) 916-733-8914 www.patrickmcgahanmd.cm Befre Surgery
More informationContinuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP
Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit
More informationDiabetes: HbA1c Poor Control (NQF 0059)
Diabetes: HbA1c Pr Cntrl (NQF 0059) EMeasure Name Diabetes: HbA1c Pr Cntrl EMeasure Id Pending Versin Number 1 Set Id Pending Available Date N infrmatin Measurement January 1, 20xx thrugh Perid December
More informationIowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training
Iwa Early Peridic Screening, Diagnsis and Treatment Care fr Kids Prgram Prvider Training The Early Peridic Screening, Diagnsis and Treatment (EPSDT) Care fr Kids prgram is Iwa s Medicaid prgram fr children.
More informationHospital Preparedness Checklist
Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been
More informationRoche Modular Auto-Verification Settings Guidelines
SMILE Jhns Hpkins University Baltimre, MD USA Rche Mdular Aut-Verificatin Settings Guidelines Rche Mdular Aut Verificatin Settings Guideline Number Equ2.9-02-G Authrs: Penny S. Stevens & Kurt L. Michael
More informationDental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.
Dental Benefits Under the TeamstersCare Plan, yu and yur eligible dependents have three basic ptins when yu need dental care. Optin #1: TeamstersCare Dentists. Yu can use ur in-huse Charlestwn, Chelmsfrd,
More information2017 CMS Web Interface
CMS Web Interface PREV-9 (NQF 0421): Preventive Care and Screening: Bdy Mass Index (BMI) Screening and Fllw- Measure Steward: CMS Web Interface V1.0 Page 1 f 23 11/15/2016 Cntents INTRODUCTION... 3 WEB
More information2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizations, Clinical Cascade Breakout Session TB/HIV EXERCISE
2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizatins, Clinical Cascade Breakut Sessin TB/HIV EXERCISE Created by the ICPI TB/HIV Wrkstream Abut this Handut
More information2013 DATA COLLECTION GUIDE Summary Data Submission. Optimal Asthma Care. (07/01/2012 to 06/30/2013 Dates of Service)
2013 DATA COLLECTION GUIDE Summary Data Submissin Optimal Asthma Care (07/01/2012 t 06/30/2013 Dates f Service) Htline: 612-746-4522 E-mail: supprt@mncm.rg Data Prtal: https://data.mncm.rg/lgin MN Cmmunity
More informationCommissioning Policy: South Warwickshire CCG (SWCCG)
Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationPercutaneous Nephrolithotomy (PCNL)
Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this
More informationSchool Medication Authorization Form. School Grade Teacher. Emergency Phone No: To be completed by the student's physician: Name of Medication:
Schl Medicatin Authrizatin Frm Student's Name Address Birth Date Hme Phne Schl Grade Teacher Emergency Phne N: T be cmpleted by the student's physician: Name f Medicatin: Dsage Frequency Time t be given
More informationMeasure Specific Guidelines for Comprehensive Diabetes Care (CDC)
Measure Specific Guidelines fr Cmprehensive Diabetes Care (CDC) Descriptin: Members age 18-75 years f age with diabetes (Type 1 and Type 2)* that had all f the fllwing: *Members in hspice are excluded
More informationArchitecture for Research Computing in Health (ARCH) Using i2b2 to Find Patient Cohorts of Interest
Architecture fr Research Cmputing in Health (ARCH) Using i2b2 t Find Patient Chrts f Interest T access i2b2, please visit https://i2b2.med.crnell.edu/webclient/ and lgin with yur CWID and passwrd. T request
More informationI am having a Rotator Cuff Repair
I am having a Rtatr Cuff Repair A rtatr cuff repair is surgery t repair a trn tendn in the shulder. The rtatr cuff is a grup f muscles and tendns that frm a cuff ver the shulder jint. The muscles and tendns
More informationCreating and Linking Charge Objects
Overview Charge bject screens are used t maintain cst accunting cdes that agencies use t break ut emplyee time based n wrk perfrmed and leave time while assigned t a specific prject(s). The charge bject
More informationDATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this
More informationAnnual Principal Investigator Worksheet About Local Context
Cmpleting the NCI CIRB Annual Principal Investigatr Wrksheet Abut Lcal Cntext and the Study-Specific Wrksheet Abut Lcal Cntext at the University f Iwa All investigatrs cnducting research with the Natinal
More informationImmunisation and Disease Prevention Policy
Immunisatin and Disease Preventin Plicy Quality Area 2: Children s Health and Safety 2.1 Each child s health is prmted 2.1.4 Steps are taken t cntrl the spread f infectius diseases and t manage injuries
More informationSection 5. Study Procedures
Sectin 5. Study Prcedures 5.1 Visit Lcatins... 1 5.2 Eligibility Determinatin... 1 5.3 Screening Visit... 2 5.3.1 Screening and Enrllment Timeframe... 2 5.3.2 Screening Visit Prcedures... 2 5.3.3 Screening
More informationMethadone Maintenance Treatment for Opioid Dependence
POLICY STATEMENT Methadne Maintenance Treatment fr Opiid Dependence APPROVED BY COUNCIL: May 2010 PUBLICATION DATE: Dialgue, Issue 2, 2010 Disclaimer: As f May 19, 2018 physicians n lnger require an exemptin
More informationPodcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10
Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family
More information(Please text me on once you have submitted your request online and the cell number you used)
Dear Thank yu fr yur email, nted. Belw steps n hw t register as a service prvider. Please nte that nce yu have requested t becme a service prvider, yu need t sms/what s up me n 0826392585, in rder t activate
More informationMichigan Primary Care Transformation Project Performance Incentive Technical Manual
Michigan Primary Care Transfrmatin Prject 2016 Perfrmance Incentive Technical Manual Fr Physician Organizatins, Physician Hspital Organizatins, Independent Practice Assciatins and Primary Care Practices
More informationWeight Assessment and Counseling for Children and Adolescents (NQF 0024)
Weight Assessment and Cunseling fr Children and Adlescents (NQF 0024) EMeasure Name Weight Assessment and EMeasure Id Pending Cunseling fr Children and Adlescents Versin Number 1 Set Id Pending Available
More informationAssessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams
Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.
More informationAction plan: serialisation of Nordic packages focus on Product Codes
19.6.2017, versin 5 Actin plan: serialisatin f Nrdic packages fcus n Prduct Cdes The aim f this dcument is t help pharma cmpanies t prepare fr prduct cde changes and t be able t maintain prduct cdes in
More informationOral Surgery (Facial Pain) Service Specification
Oral Surgery (Facial Pain) Service Specificatin Service Cmmissiner Lead Prvider Lead Perid 2. Oral Surgery Facial Pain (SBCH Ref N. SS_046) 1. Purpse 1.1 Aims T prvide a Cnsultant-led specialist diagnstic,
More informationFDA Dietary Supplement cgmp
FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes
More informationMeaningful Use Roadmap Stage Edition Eligible Hospitals
Meaningful Use Radmap Stage 1-2011 Editin Eligible Hspitals CPSI is dedicated t making yur transitin t Meaningful Use as seamless as pssible. Therefre, we have cme up with a radmap t assist yu in implementing
More informationGuideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations
Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT INJECTIONS OR BLOCKS CPT Cdes: Cervical Thracic Regin: 64490 (+ 64491, +64492), 0213T (+0214T, +0215T) Lumbar Sacral Regin:
More informationPublic consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking
Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment
More informationCognitive enhancers for the treatment of Alzheimer s disease
Cmprehensive Research Plan: Cgnitive enhancers fr the treatment f Alzheimer s disease Pharmacepidemilgy Unit February 13 th, 2015 30 Bnd Street, Trnt ON, M5B 1W8 www.dprn.ca inf@dprn.ca 2 ODPRN Drug Class
More information2018 CMS Web Interface
CMS Web Interface PREV-9 (NQF 0421): Preventive Care and Screening: Bdy Mass Index (BMI) Screening Measure Steward: CMS CMS Web Interface V2.0 Page 1 f 23 11/13/2017 Cntents INTRODUCTION... 3 CMS WEB INTERFACE
More information2018 CMS Web Interface
CMS Web Interface PREV-9 (NQF 0421): Preventive Care and Screening: Bdy Mass Index (BMI) Screening Measure Steward: CMS CMS Web Interface V2.1 Page 1 f 24 06/25/ Cntents INTRODUCTION... 3 CMS WEB INTERFACE
More informationChildhood Immunization Status (NQF 0038)
Childhd Immunizatin Status (NQF 0038) EMeasure Name Childhd Immunizatin EMeasure Id Pending Status Versin Number 1 Set Id Pending Available Date N infrmatin Measurement Perid January 1, 20xx thrugh December
More informationSTATISTICAL ANALYSIS PLAN. Addendum 1 (V 1 12SEP2015)
Pelvic Flr Disrder STATISTICAL ANALYSIS PLAN Addendum 1 (V 1 12SEP2015) PFDN Prtcl Number 22P01: Refractry Overactive Bladder: Sacral NEurmdulatin v. BTulinum Txin Assessment (ROSETTA) AUTHOR (S): Tracy
More informationPROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.
Cmprehensive Diagnstic Evaluatin (CDE) Guidelines t Access the Applied Behavir Analysis (ABA) Benefit May 5, 2017 Clinical infrmatin that utlines medical necessity is required t supprt the need fr initial
More information